Clinical Trials Logo
  1. Home
  2. HCV Coinfection
  3. NCT03646396

Effect of Sofosbuvir-daclatasuvir on Angiogenesis

HCV Coinfection Clinical Trial

Official title:
Effect of Daclatasvir Plus Sofosbuvir on Angiogenesis in Egyptian Patients With Chronic HCV Infection

Clinical Trial Summary

The study aimed at study of the Effect of Daclatasvir Plus Sofosbuvir on Angiogenesis in Egyptian Patients With Chronic HCV Infection

Clinical Trial Description

The study primary aim was at evaluation of the Effect of Daclatasvir Plus Sofosbuvir on Angiogenesis in Egyptian Patients With Chronic HCV Infection ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03646396
Study type Interventional
Source Tanta University
Contact Sherief Abd-Elsalam, MD
Phone 00201147773440
Email sheriefabdelsalam@yahoo.com
Status Recruiting
Phase N/A
Start date August 1, 2018
Completion date December 2025
View Details
See also
  Status Clinical Trial Phase
Completed NCT02810275 - Folinic Acid: Supplementation and Therapy Phase 3
Completed NCT03145753 - Education vs Education Plus Intervention in HIV/HCV Diagnosis (DRIVE 03) N/A
Completed NCT01557998 - Testing and Linkage to Care for Injecting Drug Users in Kenya N/A
Completed NCT01335529 - Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin Phase 2
Completed NCT03499639 - Ombitasvir/ Paritaprevir / Ritonavir Plus Ribavirin in Management HCV and End-stage Kidney Disease Phase 4
Completed NCT01222611 - HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir Phase 4
Completed NCT03050905 - Proof of Concept Study To Evaluate the Efficacy and Justification Of OBV/PTV/r and DSV In Adults With Chronic Hepatitis C Virus Genotype 2K/1B Phase 4
Completed NCT02505243 - Evaluation of RIBAvirin Plasma COncentrations in Patients With Chronic Hepatitis C Infection Routinely Treated With Modern DAA Regimens
Recruiting NCT02086708 - Ultrasound Method to Measure Fibrosis of the Liver in Children N/A
Completed NCT03508115 - Changes in Cognition in HCV Patients After Virus Eradication With Direct Antiviral Agents
Completed NCT03214679 - Accessible HCV Care Intervention for People Who Inject Illicit Drugs (PWID) N/A
Completed NCT02938013 - deLIVER: Direct Acting Antiviral Effects on the Liver Phase 4
Completed NCT03549832 - Comparative Study of Two Regiemns in Management of Sofosbuvir/Daclatasvir Failure N/A
Completed NCT01900015 - Changes in Liver Steatosis After Switching to Raltegravir in HIV/HCV Coinfection Phase 4
Active, not recruiting NCT01529073 - Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection Phase 2
Recruiting NCT01747772 - Sonoelastography: Ultrasound Method to Measure Liver Fibrosis N/A
Completed NCT02693847 - Natural History of Liver Cirrhosis Diagnosed by Transient Elastography in HIV/HCV-coinfected Patients
Recruiting NCT03549312 - Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy Phase 4
Completed NCT03252483 - Integrating HIV and Hepatitis C Screening in an Urban Emergency Department N/A
Completed NCT01335230 - The Study of Gut Associated Lymphocytes in HIV and HCV/HIV Co-infected Patients N/A